Invited speakers

Plenary Speakers

Alzheimer Treatment: Past, present and future

Brain Dimensions of Depression: From Biomarkers to Home-Based Neuromodulation

Alzheimer Treatment: Past, present and future

Prof. Ricardo F. Allegri

Professor of Neurology
School of Medicine, Universidad de Buenos Aires

Head of Department of Cognitive Neurology, Neuropsychology and Neuropsychiatry, Instituto de Investigaciones Neurológicas Fleni

Buenos Aires, Argentina

Click here for Bio

Brain Dimensions of Depression: From Biomarkers to Home-Based Neuromodulation

Prof. Cynthia Fu

Professor of Affective Neuroscience

Director, Affective Clinical Neuroscience Unit, Department of Psychology and Human Development, University of East London

London, United Kingdom

Click here for Bio

Debate Speakers

Cannabis use in adolescence negatively impacts emerging adults' neurodevelopmental and cognitive abilities’

Prof. Robin Murray

Professor of Psychiatric Research
Institute of Psychiatry, Psychology and Neuroscience,
King’s College

London, United Kingdom

Click here for Bio

Dr. Debasish Basu

Former Professor and Head
Department of Psychiatry,
Postgraduate Institute of Medical Education & Research (PGIMER)

Chandigarh, India

Click here for Bio

Are GLP-1 receptor agonists the new frontier in the treatment of psychiatric disorders?

Prof. Dan Siskind

Professor
University of Queensland,
Faculty of Health,
Medicine and Behavioural Science

Brisbane, Australia

Click here for Bio

Prof. Andreas Reif

Chair
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy,
University Medical Centre Frankfurt

Frankfurt, Germany

Click here for Bio

Immuno-metabolic depression: Is it prime time to adopt immuno-metabolic modulating pharmacological and lifestyle interventions?

Prof. Jane A. Foster

Professor
Center for Depression Research and Clinical Care, 
Division of General Psychiatry, 
UT Southwestern Medical Center

Dallas, United States

Click here for Bio

Prof Gin S. Malhi

School of Psychiatry,
University of New South Wales

Sydney, Australia

Click here for Bio

State-of-the-Art Session Speakers

Advances in Psychosis: Real Advances and Chimeras Over the Past Half-Century

Cognitive neuroscience of antidepressant action- what’s new and why does it matter?

Advances in Psychosis: Real Advances and Chimeras Over the Past Half-Century

Prof. Robin Murray

Professor of Psychiatric Research
Institute of Psychiatry, Psychology and Neuroscience,
King’s College

London, United Kingdom

Click here for Bio

Cognitive neuroscience of antidepressant action- what’s new and why does it matter?

Prof. Catherine Harmer

Professor of Cognitive Neuroscience

Associate Head of Department People & Culture,
University of Oxford
Warneford Hospital

Oxford, United Kingdom

Click here for Bio

Presidential Symposium Speakers

Beyond DSM-5: What Comes Next—and Why It Matters’ or ‘The Future of Diagnosis: Inside the Next DSM

Prof. Anissa Abi-Dargham

Chair
Psychiatry and Behavioral Health
Stony Brook Medicine

New York, United States

Click here for Bio

Nitin Gogtay, MD

VP
Division of Research
Deputy Medical Director

American Psychiatric Association

Bethesda, United States

Click here for Bio

Drug Pipeline Symposium Speakers

Ravi Anand, MD

Chief Medical Officer 
Newron Pharmaceuticals SpA

Bresso, Italy

Click here for Bio

Pablo Lapuerta, MD

Founder and CEO
4M Therapeutics

Princeton, United States

Click here for Bio

Conference Secretariat

GCBP 2026

gcbp2026@gmail.com

Conference Manager

Neumech Events
11, Ground Floor, Ansal Tower – 38, Nehru Place,
New Delhi – 110019, India
Mobile: +91 97172 98178
E: desk@conferenceindia.org
Web: www.neumechevents.com